NLS Pharmaceutics | We design affordable, safe and effective drugs to safeguard and empower the brain throughout all stages of life. Our aim is to improve quality of life and longevity. We are creating new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people.

Welcome to NLS Pharmaceutics

Jul 3, 2019
NLS Pharmaceutics Ltd. (NLS) Announces Notice of Allowance of two new Patents in North America Covering Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy further bolstering its Patent Portfolio
Mar 19, 2019
NLS Pharmaceutics Announces the Completion of the Merger between NLS Pharma Ltd., NLS- 1 Pharma Ltd. and NLS-0 Pharma, Unifying the Global Operations and Development of Nolazol®
Feb 25, 2019
NLS-1 Pharma and Eurofarma Enter to an Exclusive Licensing Agreement to Develop and Commercialize Nolazol® for the Treatment of ADHD in Latin America
Aug 24, 2018
NLS-1 Pharma is awarded in "The 30 Fastest Growing Companies to Watch" by CIO Bulletin Magazine